Vycor Medical (VYCO) FCF Margin (2010 - 2026)

Vycor Medical (VYCO) has 17 years of FCF Margin data on file, last reported at 21.68% in Q1 2026.

• On a quarterly basis, FCF Margin rose 2785.0% year-over-year to 21.68% in Q1 2026; TTM through Mar 2026 was 5.9%, a 405.0% increase from a year earlier, with the FY2025 full-year figure at 1.0%, down 445.0% from the prior year.
• FCF Margin for Q1 2026 stood at 21.68%, up from 9.03% in the prior quarter.
• Over the last five years, FCF Margin for VYCO reached as high as 21.68% in Q1 2026 and fell as low as 25.1% in Q1 2022.
• Historically, FCF Margin has averaged 1.76% across 5 years, with a median of 0.13% in 2023.
• Across the five-year window, FCF Margin tumbled 2449 bps in 2022 and soared 3192 bps in 2023, its largest moves.
• Year by year, FCF Margin stood at 12.18% in 2022, then surged by 99 bps to 0.13% in 2023, then slumped by 6445 bps to 8.41% in 2024, then soared by 207 bps to 9.03% in 2025, then surged by 140 bps to 21.68% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 21.68% in Q1 2026, 9.03% in Q4 2025, and 14.1% in Q3 2025.